HBV
  • Featured content
    In this CME-certified video module, Leonard H. Calabrese, DO; Robert P. Perrillo, MD, FAASLD; and Andrew D. Zelenetz, MD, PhD, discuss best practices in HBV screening and prophylaxis for patients who will undergo immunosuppressive therapy.
  • Featured content
    In this CME-certified video module, Leonard H. Calabrese, DO; Robert P. Perrillo, MD, FAASLD; and Andrew D. Zelenetz, MD, PhD, discuss best practices in HBV screening and prophylaxis for patients who will undergo immunosuppressive therapy.
  • Featured content
    In this CME-certified video module, Leonard H. Calabrese, DO; Robert P. Perrillo, MD, FAASLD; and Andrew D. Zelenetz, MD, PhD, discuss best practices in HBV screening and prophylaxis for patients who will undergo immunosuppressive therapy.
  • Featured content
    In this downloadable slideset, Leonard H. Calabrese, DO; Robert P. Perrillo, MD, FAASLD; and Andrew D. Zelenetz, MD, PhD, review HBV reactivation risk, screening, and prophylaxis for patients who will undergo immunosuppressive therapy.
    Date Posted: 10/18/2016
  • Featured content
    In this downloadable slideset, Leonard H. Calabrese, DO; Robert P. Perrillo, MD, FAASLD; and Andrew D. Zelenetz, MD, PhD, review HBV reactivation risk, screening, and prophylaxis for patients who will undergo immunosuppressive therapy.
    Date Posted: 10/18/2016
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 404 Shown
10 of 404 Shown
Show 10 More
Loading...